The Pathfinder programme supports the exploration of bold ideas for radically new technologies. Calls for proposals begin in June, and the application deadline is October.
A good Pathfinder project should have:
- Interdisciplinary scientific collaboration at the highest level.
- Visionary thinkers and ideas.
- a consortium of researchers and other partners from at least three different countries.
If you have what it takes, you are eligible for grants of up to €3-4 million to support early-stage development of future technologies (activities at low Technology Readiness Levels 1-3).
Not sure if you fit the framework? Talk to us! Thanks to our many years of experience, we can assess your potential and guide you through the process.
Here you can find an overview of upcoming calls:
- Climate change: Climate change, global warming and water/soil pollution are unprecedented challenges for the planet. To overcome them, it is necessary to develop breakthrough and integrated solutions to disrupt the current production processes and introduce more sustainable consumption habits. https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-eic-2022-pathfinderchallenges-01-01
- ENERGY: Energy storage is required to increase energy systems flexibility, sectors coupling, demand response and smart interoperability solutions. Storage technologies facilitate high penetration of intermittent renewable energy, enable energy efficiency technologies such as waste heat recovery, increase the efficiency of cold supply chains and in turn contribute to the ecologic transition.https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-eic-2022-pathfinderchallenges-01-02
- Cardiogenomics : Cardiogenomics holds the potential to address existing gaps in the diagnosis and treatment of cardiovascular diseases (CVD), which would enable better outcome for the patient. Advanced genetic testing taking into account complex inheritance, or combining genetic testing, transcriptomics, proteomics and metabolomics analysis with clinical phenotype can improve clinical management of the CVD and identify more accurately, who is likely to be at risk for major cardiovascular events such as heart failure or sudden death. Many gene variants associated with CVD are of unknown significance and thus of limited clinical utility. Our ability to sub-classify CVD diseases according to their underlying molecular mechanism has been enhanced due to technological approaches such as, spatial or single-cell transcriptomics, and others. https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-eic-2022-pathfinderchallenges-01-03
- Healthcare: Today, episodic (symptom-triggered) healthcare remains the norm. To a large extent, individuals are entrusted with the responsibility to self-monitor and trigger requests to the health system upon identification of relevant symptoms. In spite of the growing number of screening programmes, the diagnosis of a vast majority of disorders, including those in which early action has a direct impact on morbidity or survival, still relies heavily on the individual to initiate the process. Further, a substantial fraction of outpatients manage the post-treatment phase, particularly of non-life threatening conditions, with qualitative self-monitoring, seeking help only upon perceived evidence of disease recurrence. In essence the current approach to healthcare is mostly reactive. https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-eic-2022-pathfinderchallenges-01-04
- Data storage: Current technologies for digital data storage are hitting sustainability limits in terms of energy consumption and their use of rare and toxic materials. Moreover, data integrity when using those technologies is limited in time, which complicates archival data-storage. DNA or certain classes of synthetic DNA alternatives provide an alternative that promises information densities that are several orders of magnitude higher than classical memories, and stability for millennia rather than years. Moreover, DNA-based data storage can profit from the growing range of DNA research, tools and techniques from the life sciences, while potentially also adding to it (e.g., for in-vivo data collection). [JTJ1]
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-eic-2022-pathfinderchallenges-01-05 - Quantum technologies: The Quantum Flagship is currently focused on mainstream quantum technologies, in qubit implementation, sensors and other areas. Nevertheless, alternative implementations/platforms and so far, unexploited (controllable) quantum principles exist and could become key elements in future quantum systems. Such new implementations and principles could lead to breakthrough innovations and enable new players to offer unique solutions for the architecture and critical building blocks of new quantum systems. This could represent a significant opportunity for European researchers and companies in this competitive field. https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-eic-2022-pathfinderchallenges-01-06
There is a lot of work to be done. So do not wait, talk to us – professional application writers who have your back. Do not stress yourself out, just relax while we do what we do best – fund your business!